When tumors were compared to normal ovarian samples, we found that VGLL3 was significantly lower in tumor samples than it was in normal ovarian samples in both the TCGA and GSE26712 cohorts (p<0.05 and p=2.4e-07, respectively) (Supplementary Figures S1B, C). The gene discussed is VGLL3; the disease is neoplasm.